Description:

NSABP PROTOCOL R-04: FORM ALERT Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B7822CF5-8853-24F1-E034-0003BA12F5E7

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B7822CF5-8853-24F1-E034-0003BA12F5E7

Keywords:
Versions (4) ▾
  1. 12/18/14
  2. 1/9/15
  3. 1/9/15
  4. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Colorectal Cancer NCT00058474 Toxicity - NSABP PROTOCOL R-04: FORM ALERT - 2082606v3.0

*Unexpected: AE not listed in drug package insert (5FU and Epoetin alfa) or in the Investigator's Brochure (Capecitabine).

Ccrr Module For Nsabp Protocol R-04: Form Alert
Are data amended?
Notify Local IRB?
Was the patient hospitalized for 24 hours or more?
CTC Adverse Event Type
Protocol Therapy
CTC Adverse Event Attribution Code

Similar models